Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Autoimmune Disorders

Free Subscription 25.08.2025 3 BMC Neurol 2 Brain 1 Curr Opin Immunol 8 Diabet Med 6 Diabetes 7 J Clin Endocrinol Metab 2 J Nephrol 4 J Neuroimmunol 9 J Neurol 4 Kidney Int 5 Mult Scler 2 N Engl J Med 1 PLoS Med 4 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Neurol

1. YIN H, Wang Y, Xu Y
   Neuromyelitis optica spectrum disorders with recurrent syncope due to area postrema syndrome: a case report and literature review.
   BMC Neurol. 2025;25:339.
   PubMed         Abstract available
   
   
2. AN Q, Liu L
   A case report of autoimmune glial fibrillary acidic protein astrocytopathy combined with Epstein-Barr virus infection.
   BMC Neurol. 2025;25:347.
   PubMed         Abstract available
   
   
3. NING Y, Liang H, Liang S, Liang X, et al
   Central nervous system infections in patients with anti-interferon-gamma autoantibodies: case series and review of the literature.
   BMC Neurol. 2025;25:345.
   PubMed         Abstract available
   
   

   
   Brain

4. PAPE K, Hanuscheck N, Schmaul S, Kneilmann F, et al
   Role of CD5 signalling for pro-inflammatory Th17 response in multiple sclerosis.
   Brain. 2025 Aug 25:awaf268. doi: 10.1093.
   PubMed         Abstract available
   
   
5. RODRIGUES P, Frare JM, Ruviaro NA, Peres DS, et al
   Advanced oxidation protein products activated TRPA1 in a neuropathic multiple sclerosis model.
   Brain. 2025 Aug 17:awaf306. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Curr Opin Immunol

6. HU Z, Zhao M
   B cell-targeted therapies in autoimmune skin disease: current advances and challenges.
   Curr Opin Immunol. 2025;96:102643.
   PubMed         Abstract available
   
   

   
   Diabet Med

7. LUND E, Vistisen D, Svensson J, Birkebaek NH, et al
   Age- and sex-dependent lipid trajectories in children and adolescents with type 1 diabetes-A Danish nationwide registry-based study.
   Diabet Med. 2025 Apr 22:e70055. doi: 10.1111/dme.70055.
   PubMed         Abstract available
   
   
8. WANG R, Kyi M, Krishnamoorthi B, Connell A, et al
   Continuous glucose monitoring during intravenous insulin infusion treatment: Assessing accuracy to enable future clinical utility.
   Diabet Med. 2025;42:e70076.
   PubMed         Abstract available
   
   
9. SWABY R, Narayan K, Scudder C, Townson J, et al
   Testing methods used to predict disease progression in children with early-stage type 1 diabetes: A systematic review and meta-analysis.
   Diabet Med. 2025 May 28:e70077. doi: 10.1111/dme.70077.
   PubMed         Abstract available
   
   
10. VU J, Solanki K, McKay J, Kumareswaran K, et al
    Diabetes distress screening using PAID-5 and PAID-1 among adults attending a tertiary multidisciplinary type 1 diabetes clinic.
    Diabet Med. 2025 Jun 8:e70083. doi: 10.1111/dme.70083.
    PubMed         Abstract available
    
    
11. WANG R, Liu W, Yang C, Weng X, et al
    Stigma experienced by adolescents with type 1 diabetes: A systematic review and meta-synthesis.
    Diabet Med. 2025 Jun 13:e70088. doi: 10.1111/dme.70088.
    PubMed         Abstract available
    
    
12. WARD JL, Cruz J, Harwood R, Kenny S, et al
    SARS-CoV-2 infection and new-onset type 1 diabetes in the post-acute period among children and young people in England.
    Diabet Med. 2025 Jun 17:e70084. doi: 10.1111/dme.70084.
    PubMed         Abstract available
    
    
13. DE ZOYSA N, Chadwick P, Ferguson C, Gianfrancesco C, et al
    Training DAFNEplus facilitators in novel behaviour change approaches: A template for training design and delivery.
    Diabet Med. 2025;42:e70078.
    PubMed         Abstract available
    
    
14. NAIR KS
    Dorothy Hodgkin lecture 2024: Insulin regulation of mitochondrial biogenesis and function-Impact of dysregulation of mitochondrial function in diabetes and its complications.
    Diabet Med. 2025 Jul 1:e70086. doi: 10.1111/dme.70086.
    PubMed         Abstract available
    
    

    
    Diabetes

15. GILLESPIE KM
    Islet Autoantibody Testing as Type 1 Diabetes Early Detection Enters Mainstream Health Care.
    Diabetes. 2025;74:1466-1468.
    PubMed        
    
    
16. PIPELLA J, Motlagh RA, Rampazzo Morelli N, Thompson PJ, et al
    Autoreactive T Cells and Cytokine Stress Drive beta-Cell Senescence Entry and Accumulation in Type 1 Diabetes.
    Diabetes. 2025 Jun 11:db241122. doi: 10.2337/db24-1122.
    PubMed         Abstract available
    
    
17. BERG-HANSEN K, Bangshaab M, Gopalasingam N, Nielsen R, et al
    The Cardiac and Hemodynamic Effects of Ketone Bodies Are Abnormal in Patients With Type 1 Diabetes: A Randomized Controlled Trial.
    Diabetes. 2025 Jun 17:db250243. doi: 10.2337/db25-0243.
    PubMed         Abstract available
    
    
18. GIANFRANI C, Camarca A, Picascia S, Vitale S, et al
    T-Cell Mediated Immunity to Gliadin Is Elicited in the Gut Mucosa of Type 1 Diabetes Patients Only in Presence of Celiac Disease Comorbidity.
    Diabetes. 2025 Jun 24:db241120. doi: 10.2337/db24-1120.
    PubMed         Abstract available
    
    
19. SHEANON N, Warner SO, Dai Y, Whitsett NH, et al
    Fasting Lowers Glucagon Levels Under Basal Conditions and During Insulin-Induced Hypoglycemia in Individuals With Type 1 Diabetes.
    Diabetes. 2025 Jun 30:db250251. doi: 10.2337/db25-0251.
    PubMed         Abstract available
    
    
20. MARINAC M, Rickels MR, Gaglia JL, O'Connell PJ, et al
    Future Directions and Clinical Trial Considerations for Novel Islet beta-Cell Replacement Therapies for Type 1 Diabetes.
    Diabetes. 2025 Jul 15:dbi240037. doi: 10.2337/dbi24-0037.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

21. WYCKOFF JA, Lapolla A, Asias-Dinh BD, Barbour LA, et al
    Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline.
    J Clin Endocrinol Metab. 2025 Jul 13:dgaf288. doi: 10.1210.
    PubMed         Abstract available
    
    
22. AL NOFAL A, Benkhadra K, Abbas A, Nduwimana MJ, et al
    A Systematic Review Supporting the Clinical Practice Guidelines on the Management of Preexisting Diabetes and Pregnancy.
    J Clin Endocrinol Metab. 2025 Jul 13:dgaf289. doi: 10.1210.
    PubMed         Abstract available
    
    
23. MICHELS AW, Brusko TM, Evans-Molina C, Homann D, et al
    Challenges and Opportunities for Understanding the Pathogenesis of Type 1 Diabetes: An Endocrine Society Scientific Statement.
    J Clin Endocrinol Metab. 2025 Jul 9:dgaf267. doi: 10.1210.
    PubMed         Abstract available
    
    
24. AMENDOLARA R, D'Onofrio L, Sessa RL, Di Giulio S, et al
    IFN-alpha neutralizing antibodies distinguish LADA from early-onset type 1 diabetes.
    J Clin Endocrinol Metab. 2025 Jan 6:dgaf001. doi: 10.1210.
    PubMed         Abstract available
    
    
25. ORSOS I, Molnar Z, Ujhelyi B, Steiber Z, et al
    Stimulation of Piezo1 mechanosensitive channels inhibits adipogenesis in thyroid eye disease.
    J Clin Endocrinol Metab. 2025 Jan 2:dgae899. doi: 10.1210.
    PubMed         Abstract available
    
    
26. YU B, Wang Y, Jin J, Liu J, et al
    CD34+ orbital fibroblasts contribute to the pathogenesis of thyroid eye disease via miR-182-5p.
    J Clin Endocrinol Metab. 2024 Dec 18:dgae876. doi: 10.1210.
    PubMed         Abstract available
    
    
27. YOSHIMURA K, Hirota Y, Saito S, Nishikage S, et al
    Prediction of insulin requirements by explainable machine learning for individuals with type 1 diabetes.
    J Clin Endocrinol Metab. 2024 Dec 11:dgae863. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    J Nephrol

28. QI F, Zeng HQ, Zhu L, Zhou P, et al
    Efficacy of methylprednisolone pulse therapy in Chinese children with IgA vasculitis-associated nephritis (IgAVN).
    J Nephrol. 2025;38:1565-1572.
    PubMed         Abstract available
    
    
29. EBRAHIMI N, Geetha D, Reyes-Bahamonde J, Zuppan CW, et al
    Correction: Effective management of lupus nephritis using a novel combination therapy with low-dose steroids: a case report.
    J Nephrol. 2025 Aug 26. doi: 10.1007/s40620-025-02408.
    PubMed        
    
    

    
    J Neuroimmunol

30. IQBAL A, Mubarak B, Amar A, Mukhtar S, et al
    Association of interleukins 17A and 22 levels and their common genetic polymorphisms in Guillain Barre syndrome.
    J Neuroimmunol. 2025;408:578721.
    PubMed         Abstract available
    
    
31. SEN S, Kurtuncu M, Demir S, Gunduz T, et al
    Comparative efficacy of rituximab versus azathioprine in the treatment of MOG antibody-associated disease (MOGAD).
    J Neuroimmunol. 2025;407:578686.
    PubMed         Abstract available
    
    
32. MORAES BF, Sucupira JCL, Junior MGO, Leite GAPD, et al
    When gut and nerves collide: A case of Neuromyelitis Optica Spectrum disorder after golimumab for ulcerative colitis.
    J Neuroimmunol. 2025;407:578700.
    PubMed         Abstract available
    
    
33. HOSHINA Y, Liu S, Wright MA, Delic A, et al
    Prolonged corticosteroid therapy and steroid-sparing maintenance immunotherapy lower relapse risk in pediatric and adult MOGAD.
    J Neuroimmunol. 2025;407:578709.
    PubMed         Abstract available
    
    

    
    J Neurol

34. MATHEY G, Epstein J, Alix T, Julien M, et al
    Cerebrospinal fluid levels of chitinase 3-like 1 and interleukin-6 can predict response to platform therapies in relapsing multiple sclerosis.
    J Neurol. 2025;272:592.
    PubMed         Abstract available
    
    
35. ADAMMEK F, Gralla W, Kupjetz M, Rademacher A, et al
    Functional exercise training in persons with multiple sclerosis: a systematic review.
    J Neurol. 2025;272:590.
    PubMed         Abstract available
    
    
36. REEVES JA, Tranquille A, Bartnik A, Mohebbi M, et al
    Paramagnetic rim lesions are associated with choroid plexus inflammation and expansion over 5 years in people with multiple sclerosis.
    J Neurol. 2025;272:585.
    PubMed         Abstract available
    
    
37. SCANDIFFIO J, Langer LK, Senthilnathan V, Feng G, et al
    Effects of psychological therapies in people with multiple sclerosis: a systematic review and network meta-analysis of randomized controlled trials.
    J Neurol. 2025;272:584.
    PubMed         Abstract available
    
    
38. ABBADESSA G, Maida E, Bonavita S, Lavorgna L, et al
    First the B cells fall, then the T cells follow: temporal immunological shift with ocrelizumab in multiple sclerosis.
    J Neurol. 2025;272:582.
    PubMed         Abstract available
    
    
39. SBAIHAT H, Roenneke K, Muller D, Ladopoulos T, et al
    MRI-based human brain atlases of R1, R2, proton density, and myelin volume fraction using synthetic quantitative imaging at 1.5 T.
    J Neurol. 2025;272:578.
    PubMed         Abstract available
    
    
40. ALFREDSSON L, Guo J, Johansson E, Olsson T, et al
    Early-life and adult body mass index in relation to MS disability progression.
    J Neurol. 2025;272:571.
    PubMed         Abstract available
    
    
41. GUERRIERI S, Gattuso I, Genchi A, Nozzolillo A, et al
    Stratify and ImmunoWELL JCV tests performances in a real-world multiple sclerosis cohort: possible clinical implications of biosimilar Natalizumab use.
    J Neurol. 2025;272:583.
    PubMed        
    
    
42. JAWORSKI M 3RD, Balconi J, Santivasci C, Youngs M, et al
    Improving conscientiousness through a smartphone app and telecoaching intervention: insights from multiple sclerosis and healthy aging samples.
    J Neurol. 2025;272:580.
    PubMed         Abstract available
    
    

    
    Kidney Int

43. CHAN EY, Marks SD
    Childhood-onset lupus nephritis: unique aspects and challenges in management.
    Kidney Int. 2025 Aug 20:S0085-2538(25)00645-3. doi: 10.1016/j.kint.2025.
    PubMed         Abstract available
    
    
44. GHASEMI M, Weins A
    Distinguishing signal from noise: a new era of autoantibody testing in podocytopathies requires thoughtful approaches.
    Kidney Int. 2025;108:349-351.
    PubMed         Abstract available
    
    
45. FU R, Wang W, Huo Y, Li L, et al
    Corrigendum to "The mechanosensitive ion channel Piezo1 contributes to podocyte cytoskeleton remodeling and development of proteinuria in lupus nephritis." Kidney International 2024;106:625-639.
    Kidney Int. 2025;108:511-512.
    PubMed        
    
    
46. REESE PP, Mohan S, Schaubel DE, Forbes R, et al
    Low prevalence of glomerulonephritis in transplanted kidneys from deceased donors with active hepatitis C virus infection.
    Kidney Int. 2025 Aug 22:S0085-2538(25)00657-X. doi: 10.1016/j.kint.2025.
    PubMed         Abstract available
    
    

    
    Mult Scler

47. JOKUBAITIS VG, Alroughani R, Altintas A, Eichau S, et al
    Four years on: Pregnancy and birth outcomes reported in the MSBase pregnancy, neonatal outcomes, and Women's Health Registry (2020-2024).
    Mult Scler. 2025;31:1088-1101.
    PubMed         Abstract available
    
    
48. KANG YR, Ju H, Kim KH, Choo SH, et al
    Outcomes of immunosuppressive therapy discontinuation in patients with myelin oligodendrocyte glycoprotein antibody-associated disease.
    Mult Scler. 2025;31:1102-1109.
    PubMed         Abstract available
    
    
49. BRIGGS FB, Genuario I, De Nadai AS, Gunzler DD, et al
    Predicting suicidal ideation at subsequent clinical encounter in multiple sclerosis patients.
    Mult Scler. 2025 Aug 25:13524585251365207. doi: 10.1177/13524585251365207.
    PubMed         Abstract available
    
    
50. ZHAO DH, Hadley G, Pisa M, Saunders P, et al
    Successful alemtuzumab retreatment in multiple sclerosis following previous diffuse alveolar haemorrhage.
    Mult Scler. 2025 Aug 20:13524585251365791. doi: 10.1177/13524585251365791.
    PubMed         Abstract available
    
    
51. KRAJNC N, Ponleitner M, Fottinger F, Leutmezer F, et al
    Serum neurofilament light chain and glial fibrillary acidic protein levels are associated with inner retinal layer thinning in multiple sclerosis.
    Mult Scler. 2025 Aug 19:13524585251360972. doi: 10.1177/13524585251360972.
    PubMed         Abstract available
    
    

    
    N Engl J Med

52. TRAPNELL BC, Inoue Y, Bonella F, Wang T, et al
    Phase 3 Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis.
    N Engl J Med. 2025;393:764-773.
    PubMed         Abstract available
    
    
53. SEYMOUR JF
    GM-CSF in Autoimmune Pulmonary Alveolar Proteinosis.
    N Engl J Med. 2025;393:812-816.
    PubMed        
    
    

    
    PLoS Med

54. CHOI EY, Bea S, Lee H, Choi A, et al
    Exposure to antibiotics during pregnancy or early infancy and the risk of autoimmune disease in children: A nationwide cohort study in Korea.
    PLoS Med. 2025;22:e1004677.
    PubMed         Abstract available
    
    

    
    PLoS One

55. ZHOU J, Zhang Z, Zhou K, Zhou L, et al
    PLA2R1 and HLA-DQA1 SNP in patients with primary membranous nephropathy.
    PLoS One. 2025;20:e0328234.
    PubMed         Abstract available
    
    
56. AKAMINE H, Uzawa A, Kuwabara S, Suzuki S, et al
    Predicting achievement of clinical goals using machine learning in myasthenia gravis.
    PLoS One. 2025;20:e0330044.
    PubMed         Abstract available
    
    
57. VINCENTINI O, Pricci F, Silano M, Agrimi U, et al
    Study protocol of D1Ce Screen: A pilot project of the Italian national screening program for type 1 diabetes and coeliac disease in the paediatric population.
    PLoS One. 2025;20:e0328624.
    PubMed         Abstract available
    
    
58. URASHIMA K, Ichinose K, Ishimaru H, Kumazaki H, et al
    Novel imaging diagnosis of neuropsychiatric systemic lupus erythematosus using topological data analysis: A retrospective study.
    PLoS One. 2025;20:e0329859.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

59. CURTIS SD, Liu T, Bai Y, Wang Y, et al
    Fragmentation signatures in cancer patients resemble those of patients with vascular or autoimmune diseases.
    Proc Natl Acad Sci U S A. 2025;122:e2426890122.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.